89bio Inc (NASDAQ:ETNB) shares, rose in value on Wednesday, February 12, with the stock price down by -1.52% to the previous day’s close as strong demand from buyers drove the stock to $11.01.
Actively observing the price movement in the last trading, the stock closed the session at $11.18, falling within a range of $10.6 and $11.12. The value of beta (5-year monthly) was 0.978. Referring to stock’s 52-week performance, its high was $16.63, and the low was $5.99. On the whole, ETNB has fluctuated by 74.48% over the past month.
With the market capitalization of 89bio Inc currently standing at about $1.60 billion, investors are eagerly awaiting this quarter’s results, scheduled for in March.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ETNB’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of ETNB currently trading nearly 22.51% and 32.88% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 68.16, while the 7-day volatility ratio is showing 5.59% which for the 30-day chart, stands at 8.83%. Furthermore, 89bio Inc (ETNB)’s beta value is 1.33, and its average true range (ATR) is 0.80.
A comparison of 89bio Inc (ETNB) with its peers suggests the former has fared considerably weaker in the market. ETNB showed an intraday change of -1.52% in last session, and over the past year, it grew by 30.30%%.
Data on historical trading for 89bio Inc (NASDAQ:ETNB) indicates that the trading volumes over the past 10 days have averaged 3.49 and over the past 3 months, they’ve averaged 2.05 million. According to company’s latest data on outstanding shares, there are 145.75 million shares outstanding.
Nearly 5.12% of 89bio Inc’s shares belong to company insiders and institutional investors own 83.70% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.34 million shares as on 2025-01-31, resulting in a short ratio of 2.61. According to the data, the short interest in 89bio Inc (ETNB) stood at 887.00 of shares outstanding as of 2025-01-31; the number of short shares registered in 2024-12-31 reached 7.79 million. The stock has risen by 40.79% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ETNB stock heading into the next quarter.
